$HSTM
HealthStream Inc

2016 Q2 Form 10-Q Financial Statement

#000119312516666525 Filed on August 01, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $54.79M $52.15M
YoY Change 5.08% 22.76%
Cost Of Revenue $22.62M $22.43M
YoY Change 0.85% 19.71%
Gross Profit $32.17M $29.71M
YoY Change 8.27% 25.17%
Gross Profit Margin 58.71% 56.98%
Selling, General & Admin $17.53M $17.08M
YoY Change 2.65% 35.41%
% of Gross Profit 54.49% 57.48%
Research & Development $7.244M $5.815M
YoY Change 24.57% 35.42%
% of Gross Profit 22.52% 19.57%
Depreciation & Amortization $5.081M $4.256M
YoY Change 19.38% 56.36%
% of Gross Profit 15.79% 14.32%
Operating Expenses $7.244M $22.89M
YoY Change -68.36% 35.41%
Operating Profit $2.316M $2.564M
YoY Change -9.67% -37.62%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $109.0K -$44.00K
YoY Change -347.73% -291.3%
Pretax Income $2.425M $2.520M
YoY Change -3.77% -39.03%
Income Tax $1.022M $1.047M
% Of Pretax Income 42.14% 41.55%
Net Earnings $1.403M $1.473M
YoY Change -4.75% -37.69%
Net Earnings / Revenue 2.56% 2.82%
Basic Earnings Per Share $0.04 $0.05
Diluted Earnings Per Share $0.04 $0.05
COMMON SHARES
Basic Shares Outstanding 31.74M shares 29.23M shares
Diluted Shares Outstanding 32.07M shares 29.62M shares

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $138.8M $139.9M
YoY Change -0.79% 25.13%
Cash & Equivalents $66.80M $54.49M
Short-Term Investments $72.00M $85.40M
Other Short-Term Assets $8.312M $6.511M
YoY Change 27.66% 61.24%
Inventory
Prepaid Expenses
Receivables $42.01M $33.41M
Other Receivables $0.00 $0.00
Total Short-Term Assets $204.5M $198.9M
YoY Change 2.83% 24.0%
LONG-TERM ASSETS
Property, Plant & Equipment $11.14M $11.28M
YoY Change -1.28% 19.16%
Goodwill $88.63M $83.99M
YoY Change 5.52% 94.27%
Intangibles
YoY Change
Long-Term Investments $3.600M $2.800M
YoY Change 28.57%
Other Assets $375.0K $1.217M
YoY Change -69.19% 26.64%
Total Long-Term Assets $172.7M $172.5M
YoY Change 0.12% 112.89%
TOTAL ASSETS
Total Short-Term Assets $204.5M $198.9M
Total Long-Term Assets $172.7M $172.5M
Total Assets $377.2M $371.4M
YoY Change 1.57% 53.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.742M $3.049M
YoY Change -42.87% 131.16%
Accrued Expenses $10.96M $9.658M
YoY Change 13.48% 3.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $81.74M $86.96M
YoY Change -6.0% 15.88%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.069M $2.598M
YoY Change -58.85% 322.44%
Total Long-Term Liabilities $1.069M $2.598M
YoY Change -58.85% 322.44%
TOTAL LIABILITIES
Total Short-Term Liabilities $81.74M $86.96M
Total Long-Term Liabilities $1.069M $2.598M
Total Liabilities $82.81M $89.56M
YoY Change -7.54% 18.37%
SHAREHOLDERS EQUITY
Retained Earnings $4.494M -$2.835M
YoY Change -258.52% -78.38%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $284.1M $271.9M
YoY Change
Total Liabilities & Shareholders Equity $377.2M $371.4M
YoY Change 1.57% 53.83%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income $1.403M $1.473M
YoY Change -4.75% -37.69%
Depreciation, Depletion And Amortization $5.081M $4.256M
YoY Change 19.38% 56.36%
Cash From Operating Activities -$5.420M $10.12M
YoY Change -153.56% -21.61%
INVESTING ACTIVITIES
Capital Expenditures -$2.860M -$3.280M
YoY Change -12.8% 29.13%
Acquisitions
YoY Change
Other Investing Activities -$7.730M -$56.01M
YoY Change -86.2% 574.82%
Cash From Investing Activities -$10.58M -$59.30M
YoY Change -82.16% 446.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 20.00K 68.90M
YoY Change -99.97% -28808.33%
NET CHANGE
Cash From Operating Activities -5.420M 10.12M
Cash From Investing Activities -10.58M -59.30M
Cash From Financing Activities 20.00K 68.90M
Net Change In Cash -15.98M 19.72M
YoY Change -181.03% 983.52%
FREE CASH FLOW
Cash From Operating Activities -$5.420M $10.12M
Capital Expenditures -$2.860M -$3.280M
Free Cash Flow -$2.560M $13.40M
YoY Change -119.1% -13.27%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
31739034 shares
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54493000
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1935000
CY2016Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
47200000
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31739000 shares
CY2016Q2 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
279595000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31739000 shares
CY2016Q2 us-gaap Assets
Assets
377183000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
204496000
CY2016Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
8134000
CY2016Q2 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
14716000
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2016Q2 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
510000
CY2016Q2 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
72006000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
66803000
CY2016Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
42014000
CY2016Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4002000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1742000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
58971000
CY2016Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-14000
CY2016Q2 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
27806000
CY2016Q2 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
6295000
CY2016Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
10960000
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
11885000
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
8312000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
377183000
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
54266000
CY2016Q2 us-gaap Goodwill
Goodwill
88628000
CY2016Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1069000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
81742000
CY2016Q2 us-gaap Prepaid Royalties
PrepaidRoyalties
13242000
CY2016Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3564000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
375000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11138000
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
284075000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
4494000
CY2016Q2 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
2119000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81995000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3308000
CY2015Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
31647000 shares
CY2015Q4 us-gaap Common Stocks Including Additional Paid In Capital
CommonStocksIncludingAdditionalPaidInCapital
278799000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
31647000 shares
CY2015Q4 us-gaap Assets
Assets
379569000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
209537000
CY2015Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
9053000
CY2015Q4 us-gaap Capitalized Computer Software Net
CapitalizedComputerSoftwareNet
13955000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2015Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
303000
CY2015Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
66976000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
82010000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
36348000
CY2015Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4350000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
4616000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
65098000
CY2015Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-70000
CY2015Q4 us-gaap Capitalized Computer Software Accumulated Amortization
CapitalizedComputerSoftwareAccumulatedAmortization
24130000
CY2015Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
4763000
CY2015Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
7003000
CY2015Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
8685000
CY2015Q4 us-gaap Other Assets Current
OtherAssetsCurrent
8169000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
379569000
CY2015Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
55966000
CY2015Q4 us-gaap Goodwill
Goodwill
83073000
CY2015Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
1058000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
89078000
CY2015Q4 us-gaap Prepaid Royalties
PrepaidRoyalties
14036000
CY2015Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
3640000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
927000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12471000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
280320000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1591000
CY2015Q4 us-gaap Receivables Long Term Contracts Or Programs
ReceivablesLongTermContractsOrPrograms
1998000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7000 shares
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-27502000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2347000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
42625000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
2578000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-35000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
645000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-41000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
1000000
us-gaap Net Income Loss
NetIncomeLoss
4195000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
76768000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
119000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7319000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
-3055000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-143548000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-41000
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
28000000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
88075000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1703000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
424000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
7509000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
4154000
us-gaap Costs And Expenses
CostsAndExpenses
91947000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.427 pure
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
823000
us-gaap Sales Revenue Net
SalesRevenueNet
99301000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
13678000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-820000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
374000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
7354000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-1776000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
96915000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
628000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
5713000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
748000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3124000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
19131000
us-gaap Payments For Software
PaymentsForSoftware
3566000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4054000
us-gaap Other Noncash Expense
OtherNoncashExpense
386000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
98014000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28843000 shares
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
29915000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28469000 shares
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10460000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
277000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17675000
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
28000000
dei Entity Registrant Name
EntityRegistrantName
HEALTHSTREAM INC
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
53000 shares
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001095565
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1004000
dei Document Period End Date
DocumentPeriodEndDate
2016-06-30
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-15207000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1004000
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2016
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
45522000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.09
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10221000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.09
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2959000
us-gaap Costs And Expenses
CostsAndExpenses
104069000
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.411 pure
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
932000
us-gaap Sales Revenue Net
SalesRevenueNet
108871000
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
16505000
us-gaap Increase Decrease In Prepaid Royalties
IncreaseDecreaseInPrepaidRoyalties
-794000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
127000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1051000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
56000
us-gaap Net Income Loss
NetIncomeLoss
2903000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
71220000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
240000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4929000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
5722000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15284000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
56000
us-gaap Proceeds From Sale Of Productive Assets
ProceedsFromSaleOfProductiveAssets
975000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
3141000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1755000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1123000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-552000
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
320000 shares
us-gaap Operating Income Loss
OperatingIncomeLoss
4802000
us-gaap Increase Decrease In Royalties Payable
IncreaseDecreaseInRoyaltiesPayable
-919000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-208000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-6474000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
302000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-76000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2026000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
285000
us-gaap Payments For Software
PaymentsForSoftware
4303000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3234000
us-gaap Other Noncash Expense
OtherNoncashExpense
607000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-208000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32021000 shares
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
65639000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31701000 shares
dei Trading Symbol
TradingSymbol
HSTM
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14263000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
94000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
17558000
hstm Number Of Stock Incentive Plans
NumberOfStockIncentivePlans
2 Incentive_Plan
CY2015Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
CY2015Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1938000
CY2015Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22432000
CY2015Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2015Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4256000
CY2015Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2015Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1411000
CY2015Q2 us-gaap Costs And Expenses
CostsAndExpenses
49581000
CY2015Q2 us-gaap Sales Revenue Net
SalesRevenueNet
52145000
CY2015Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
6750000
CY2015Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2015Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-62000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
1473000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2520000
CY2015Q2 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
-62000
CY2015Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
383000 shares
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2564000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1047000
CY2015Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29617000 shares
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
29234000 shares
CY2015Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5815000
CY2015Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10328000
CY2016Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21250 shares
CY2016Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
505000
CY2016Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
22622000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2016Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5081000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2016Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
1403000
CY2016Q2 us-gaap Costs And Expenses
CostsAndExpenses
52477000
CY2016Q2 us-gaap Sales Revenue Net
SalesRevenueNet
54793000
CY2016Q2 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
8529000
CY2016Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
109000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
1403000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2425000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
335000 shares
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
2316000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1022000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32071000 shares
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31736000 shares
CY2016Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7244000
CY2016Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9001000

Files In Submission

Name View Source Status
0001193125-16-666525-index-headers.html Edgar Link pending
0001193125-16-666525-index.html Edgar Link pending
0001193125-16-666525.txt Edgar Link pending
0001193125-16-666525-xbrl.zip Edgar Link pending
d182258d10q.htm Edgar Link pending
d182258dex311.htm Edgar Link pending
d182258dex312.htm Edgar Link pending
d182258dex321.htm Edgar Link pending
d182258dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hstm-20160630.xml Edgar Link completed
hstm-20160630.xsd Edgar Link pending
hstm-20160630_cal.xml Edgar Link unprocessable
hstm-20160630_def.xml Edgar Link unprocessable
hstm-20160630_lab.xml Edgar Link unprocessable
hstm-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending